TITLE

ANTIGLAUCOMA, CARBONIC ANHYDRASE INHIBITORS

AUTHOR(S)
GRIFFITH, H. WINTER
PUB. DATE
January 2010
SOURCE
Complete Guide to Prescription & Nonprescription Drugs 2012;2010, p98
SOURCE TYPE
Encyclopedia
DOC. TYPE
Article
ABSTRACT
The article presents information on carbonic anhydrase inhibitors, a drug developed to treat open-angle glaucoma and ocular hypertension, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.
ACCESSION #
44862647

 

Related Articles

  • ANTIGLAUCOMA, CARBONIC ANHYDRASE INHIBITORS.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2012, p98 

    The article presents information on carbonic anhydrase inhibitor, an antiglaucoma drug, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.

  • ANTIGLAUCOMA, ADRENERGIC AGONISTS. GRIFFITH, H. WINTER // Complete Guide to Prescription & Nonprescription Drugs 2012;2010, p92 

    The article presents information on adrenergic agonists antiglaucoma, a drug developed to treat open-angle glaucoma, secondary glaucoma and ocular hypertension, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.

  • Brinzolamide/Timolol: In Open-Angle Glaucoma and Ocular Hypertension. Croxtall, Jamie D.; Scott, Lesley J. // Drugs & Aging;2009, Vol. 26 Issue 5, p437 

    â–´ Brinzolamide 1%/timolol 0.5% fixed combination (brinzolamide/timolol) is a twice-daily eyedrops suspension comprising the carbonic anhydrase-II inhibitor brinzolamide and the b-adrenergic receptor antagonist timolol. â–´ Brinzolamide/timolol produced clinically relevant reductions in...

  • Bimatoprost and Bimatoprost/Timolol Fixed Combination in Patients with Open-Angle Glaucoma and Ocular Hypertension. Katsanos, Andreas; Dastiridou, Anna I.; Fanariotis, Michael; Kotoula, Maria; Tsironi, Evangelia E. // Journal of Ocular Pharmacology & Therapeutics;Feb2011, Vol. 27 Issue 1, p67 

    Purpose: To investigate the intraocular pressure (IOP) lowering effect of bimatoprost (BIM) 0.03% and the potential additional effect of the BIM 0.03%/timolol 0.5% fixed combination (BTFC) in eyes with ocular hypertension, primary open-angle glaucoma, or exfoliation glaucoma. Methods: Following...

  • CYCLOPLEGIC, MYDRIATIC (Ophthalmic).  // Complete Guide to Prescription & Nonprescription Drugs 2012;2008, p294 

    The article presents information on cycloplegic, mydriatic, an ophthalmic drug used to dilate the pupil of the eye. The dosage and usage information is provided. The possible adverse reactions or side effects of the drug, warnings, and precautions are discussed. Possible interaction of the drug...

  • CYCLOPENTOLATE (Ophthalmic). GRIFFITH, H. WINTER // Complete Guide to Prescription & Nonprescription Drugs 2012;2009, p290 

    The article presents information on cyclopentolate, a cycloplegic agent, including dosage, usage, adverse reactions, side effects, precautions, and possible interaction with other drugs.

  • CYCLOPLEGIC, MYDRIATIC (Ophthalmic). GRIFFITH, H. WINTER // Complete Guide to Prescription & Nonprescription Drugs 2012;2009, p294 

    The article presents information on cycloplegic and mydriatic agent, including dosage, usage, adverse reactions, side effects, precautions, and possible interaction with other drugs.

  • CARBONIC ANHYDRASE INHIBITORS.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2012, p230 

    The article presents information on carbonic anhydrase inhibitors including their dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.

  • CARBONIC ANHYDRASE INHIBITORS. GRIFFITH, H. WINTER // Complete Guide to Prescription & Nonprescription Drugs 2012;2010, p228 

    The article presents information on carbonic anhydrase inhibitors for use in treating glaucoma and epileptic seizures, including their dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics